• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults.

作者信息

Ke Calvin, Shah Baiju R, Luk Andrea O, Di Ruggiero Erica, Chan Juliana C N

机构信息

Department of Medicine, University of Toronto, Toronto, Canada.

ICES, Toronto, Canada.

出版信息

Diabetes Obes Metab. 2020 Jan;22(1):3-5. doi: 10.1111/dom.13874. Epub 2019 Oct 8.

DOI:10.1111/dom.13874
PMID:31486276
Abstract
摘要

相似文献

1
Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults.2型糖尿病的心血管结局试验：是时候纳入年轻人了。
Diabetes Obes Metab. 2020 Jan;22(1):3-5. doi: 10.1111/dom.13874. Epub 2019 Oct 8.
2
Lessons from a cardiovascular outcome trial with liraglutide in type 2 diabetes.利拉鲁肽用于2型糖尿病的心血管结局试验的经验教训。
J Diabetes Investig. 2017 Jul;8(4):431-433. doi: 10.1111/jdi.12607. Epub 2017 Feb 2.
3
Research digest: CV trials in diabetes-looking ahead.
Lancet Diabetes Endocrinol. 2018 Oct;6(10):769. doi: 10.1016/S2213-8587(18)30271-7.
4
Which person with diabetes should receive cardioprotective glucose-lowering medicines?哪些糖尿病患者应使用具有心脏保护作用的降糖药物？
J Diabetes. 2020 May;12(5):352-353. doi: 10.1111/1753-0407.13029.
5
Clinical outcomes trials and the cardiovascular effects of thiazolidinediones: implications for the evaluation of antidiabetic drugs.噻唑烷二酮类药物的临床疗效试验及心血管效应：对降糖药物评估的启示
Am Heart J. 2010 Jul;160(1):1-2. doi: 10.1016/j.ahj.2010.05.019. Epub 2010 May 31.
6
The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group.非胰岛素依赖型糖尿病、高血压、微量白蛋白尿或蛋白尿、心血管事件与雷米普利（DIABHYCAR）研究：设计、组织与患者招募。DIABHYCAR研究组
Control Clin Trials. 2000 Aug;21(4):383-96. doi: 10.1016/s0197-2456(00)00060-x.
7
[A search for novel pathways of effective prevention of cardiovascular complications in patients with type 2 diabetes mellitus: advance trial].[探索2型糖尿病患者心血管并发症有效预防的新途径：前瞻性试验]
Kardiologiia. 2007;47(10):90-5.
8
Reducing cardiovascular risk in type 2 diabetes: Let's use all we have!降低2型糖尿病患者的心血管疾病风险：让我们充分利用现有资源！
Int J Cardiol. 2020 Jul 1;310:155-156. doi: 10.1016/j.ijcard.2020.04.014. Epub 2020 Apr 13.
9
Cardiovascular safety evaluation in the development of new drugs for diabetes mellitus.
Circulation. 2014 Jun 24;129(25):2705-13. doi: 10.1161/CIRCULATIONAHA.113.008221.
10
Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi.肯尼亚2型糖尿病患者的心血管危险因素：在内罗毕肯雅塔国家医院门诊糖尿病诊所所达到的控制水平。
East Afr Med J. 2006 Jul;83(7):405-6; author reply 406-7.

引用本文的文献

1
Ethnic diversity in precision medicine: a reality or an aspiration?精准医学中的种族多样性：是现实还是愿景？
Diabetologia. 2025 Aug 7. doi: 10.1007/s00125-025-06513-4.
2
Young-onset type 2 diabetes-Epidemiology, pathophysiology, and management.青年发病型2型糖尿病——流行病学、病理生理学及管理
J Diabetes Investig. 2025 Jul;16(7):1157-1172. doi: 10.1111/jdi.70081. Epub 2025 May 24.
3
Ahmedabad declaration: A framework to combat growing epidemic of young-onset type 2 diabetes in Asia.艾哈迈达巴德宣言：应对亚洲青少年2型糖尿病日益流行的框架。
Diabetes Metab Syndr. 2025 Feb;19(2):103205. doi: 10.1016/j.dsx.2025.103205. Epub 2025 Feb 13.
4
Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes-Randomized Controlled Trial (PRISM-RCT) in Chinese patients with young-onset diabetes: design, methods and baseline characteristics.精准医学重新定义胰岛素分泌和单基因糖尿病随机对照试验（PRISM-RCT）在中国年轻起病糖尿病患者中的应用：设计、方法和基线特征。
BMJ Open Diabetes Res Care. 2024 Jun 19;12(3):e004120. doi: 10.1136/bmjdrc-2024-004120.
5
Young-Onset Diabetes in East Asians: From Epidemiology to Precision Medicine.东亚青少年起病型糖尿病：从流行病学到精准医学。
Endocrinol Metab (Seoul). 2024 Apr;39(2):239-254. doi: 10.3803/EnM.2024.1968. Epub 2024 Apr 16.
6
Changing landscape of diabetes in Asia - What are the unmet needs?亚洲糖尿病领域的变化格局——存在哪些未满足的需求？
J Diabetes Investig. 2024 Apr;15(4):402-409. doi: 10.1111/jdi.14150. Epub 2024 Jan 24.
7
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR.真实世界证据在治疗决策、监管评估及理解2型糖尿病患者观点中的作用：以格列齐特缓释片为例
Diabetes Ther. 2023 Oct;14(10):1609-1625. doi: 10.1007/s13300-023-01458-6. Epub 2023 Aug 21.
8
Age- and sex-specific hospital bed-day rates in people with and without type 2 diabetes: A territory-wide population-based cohort study of 1.5 million people in Hong Kong.年龄和性别特异性住院床日率在 2 型糖尿病患者和非患者中的差异：香港 150 万人群的全港范围基于人群的队列研究。
PLoS Med. 2023 Aug 4;20(8):e1004261. doi: 10.1371/journal.pmed.1004261. eCollection 2023 Aug.
9
Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong.年龄特异性人口归因风险因素与 2 型糖尿病全因和死因死亡率：对香港超过 36 万人 6 年前瞻性队列研究的分析。
PLoS Med. 2023 Jan 30;20(1):e1004173. doi: 10.1371/journal.pmed.1004173. eCollection 2023 Jan.
10
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice.2 型糖尿病的心脏肾脏疾病：临床试验与真实世界实践。
Nat Rev Endocrinol. 2023 Mar;19(3):151-163. doi: 10.1038/s41574-022-00776-2. Epub 2022 Nov 29.